ArticleMolecular oncology2022

FGF7/FGFR2-JunB signalling counteracts the effect of progesterone in luminal breast cancer.

Kamil Mieczkowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.